Cargando…

Correction: Long Term Natural History Data in Ambulant Boys with Duchenne Muscular Dystrophy: 36-Month Changes

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373841/ https://www.ncbi.nlm.nih.gov/pubmed/25806823 http://dx.doi.org/10.1371/journal.pone.0121882

Ejemplares similares

Correction: Long Term Natural History Data in Ambulant Boys with Duchenne Muscular Dystrophy: 36-Month Changes
por: Pane, Marika, et al.
Publicado: (2015)

Long Term Natural History Data in Ambulant Boys with Duchenne Muscular Dystrophy: 36-Month Changes
por: Pane, Marika, et al.
Publicado: (2014)

Correction: 24 Month Longitudinal Data in Ambulant Boys with Duchenne Muscular Dystrophy
por: Mazzone, Elena Stacy, et al.
Publicado: (2013)

24 Month Longitudinal Data in Ambulant Boys with Duchenne Muscular Dystrophy
por: Mazzone, Elena Stacy, et al.
Publicado: (2013)

Correction: Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53
por: Brogna, Claudia, et al.
Publicado: (2019)

Correction: Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study
por: Boca, Simina M., et al.
Publicado: (2016)

The 6 Minute Walk Test and Performance of Upper Limb in Ambulant Duchenne Muscular Dystrophy Boys
por: Pane, Marika, et al.
Publicado: (2014)

Muscular response to the first three months of deflazacort treatment in boys with Duchenne muscular dystrophy
por: Jensen, L., et al.
Publicado: (2017)

Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53
por: Brogna, Claudia, et al.
Publicado: (2019)

Growth pattern trajectories in boys with Duchenne muscular dystrophy
por: Stimpson, Georgia, et al.
Publicado: (2022)

Language Development in Preschool Duchenne Muscular Dystrophy Boys
por: Chieffo, Daniela Pia Rosaria, et al.
Publicado: (2022)

Preserved thenar muscles in non‐ambulant Duchenne muscular dystrophy patients
por: Naarding, Karin J., et al.
Publicado: (2021)

Peak functional ability and age at loss of ambulation in Duchenne muscular dystrophy
por: Zambon, Alberto A., et al.
Publicado: (2022)

Evaluation of Cardiac, Autonomic Functions in Ambulant Patients with Duchenne Muscular Dystrophy
por: Nayak, Amritharekha, et al.
Publicado: (2023)

Long-Term Pulmonary Function in Duchenne Muscular Dystrophy: Comparison of Eteplirsen-Treated Patients to Natural History
por: Kinane, T. Bernard, et al.
Publicado: (2018)

Correction: Expression profiling of disease progression in canine model of Duchenne muscular dystrophy
por: Brinkmeyer-Langford, Candice, et al.
Publicado: (2020)

Skeletal disproportion in glucocorticoid-treated boys with Duchenne muscular dystrophy
por: Kao, Kung-Ting, et al.
Publicado: (2019)

Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy
por: Mendell, Jerry R., et al.
Publicado: (2016)

Correction: Magnetic Resonance Imaging and Spectroscopy Assessment of Lower Extremity Skeletal Muscles in Boys with Duchenne Muscular Dystrophy: A Multicenter Cross Sectional Study
Publicado: (2014)

Therapeutic effects of aquatic exercises on a boy with Duchenne muscular dystrophy
por: Atamturk, Hakan, et al.
Publicado: (2018)

Transaminitis in a Three-year-old Boy with Duchenne Muscular Dystrophy
por: Xie, Qiuli, et al.
Publicado: (2020)

Modeling Early Heterogeneous Rates of Progression in Boys with Duchenne Muscular Dystrophy
por: Fang, Yuan, et al.
Publicado: (2023)

Comparison of Long-term Ambulatory Function in Patients with Duchenne Muscular Dystrophy Treated with Eteplirsen and Matched Natural History Controls
por: Mendell, Jerry R., et al.
Publicado: (2021)

MRI vastus lateralis fat fraction predicts loss of ambulation in Duchenne muscular dystrophy
por: Naarding, Karin J., et al.
Publicado: (2020)

Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test
por: Pane, Marika, et al.
Publicado: (2015)

Physical training in boys with Duchenne Muscular Dystrophy: the protocol of the No Use is Disuse study
por: Jansen, Merel, et al.
Publicado: (2010)

Revised North Star Ambulatory Assessment for Young Boys with Duchenne Muscular Dystrophy
por: Mercuri, Eugenio, et al.
Publicado: (2016)

Bioelectrical impedance vector analysis and phase angle in boys with Duchenne muscular dystrophy
por: Vermeulen, Karina M., et al.
Publicado: (2019)

Celiac Disease in a Boy with Duchenne Muscular Dystrophy: A Double Jeopardy!
por: Sharawat, Indar K., et al.
Publicado: (2020)

Effects of Bisphosphonate Therapy on Bone Mineral Density in Boys with Duchenne Muscular Dystrophy
por: Ronsley, Rebecca, et al.
Publicado: (2020)

Eteplirsen Use in a Boy with Duchenne Muscular Dystrophy and Sickle Cell Anemia
por: Aiello, Gregory M., et al.
Publicado: (2022)

Correction: A Randomized, Double-Blind Trial of Lisinopril and Losartan for the Treatment of Cardiomyopathy in Duchenne Muscular Dystrophy
Publicado: (2015)

Correction: Correction: Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy
Publicado: (2019)

Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients
por: McDonald, Craig M, et al.
Publicado: (2021)

Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study
por: Boca, Simina M., et al.
Publicado: (2016)

Natural history of cardiac function in Duchenne and Becker muscular dystrophies on home mechanical ventilation
por: Fayssoil, Abdallah, et al.
Publicado: (2018)

Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy
por: van Putten, Maaike, et al.
Publicado: (2019)

The Canadian experience with long term deflazacort treatment in Duchenne muscular dystrophy
por: McADAM, LAURA C., et al.
Publicado: (2012)

Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy
por: Alfano, Lindsay N., et al.
Publicado: (2019)

Correction: Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy
por: Siemionow, Maria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pc23foccqoiuo2j4qoev8lfu4g